why choose us

First received: September 28, 2022

Clinical Trial: A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pulmonary Arterial Hypertension

Study Type: INTERVENTIONAL


Official Title: Comprehensive O2 Transfer Analysis From the Lung to Mitochondria of Inhaled Treprostinil in Interstitial Lung Disease Pulmonary Hypertension

Brief Summary: The purpose of this research study is to find out more about the drug treprostinil via inhaler and the mechanisms of why patients with pulmonary arterial hypertension related to Interstitial Lung disease (PAH-ILD) have limitations during exercise.The investigator is studying treprostinil's effect on patients with PAH-ILD during exercise and its effect on their quality of life after using it for 3 months.

Read more